Lab-on-a-chip technologies for minimally invasive molecular sensing of diabetic retinopathy

Author:

Vieira Maria1,Fernandes Rosa2345ORCID,Ambrósio António F.2345ORCID,Cardoso Vanessa67,Carvalho Mariana1ORCID,Weng Kung Peng8ORCID,Neves Miguel António Dias9ORCID,Mendes Pinto Inês19ORCID

Affiliation:

1. International Iberian Nanotechnology Laboratory (INL), Braga, Portugal

2. Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal

3. Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal

4. Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal

5. Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal

6. CMEMS-UMinho, University of Minho, Campus of Azurém, Guimarães, Portugal

7. LABBELS – Associate Laboratory, Guimarães, Braga, Portugal

8. Spin Dynamics in Health Engineering Group, Songshan Lake Materials Laboratory, Dongguan, China

9. Institute for Research and Innovation in Health (i3S), Porto, Portugal

Abstract

Diabetic retinopathy (DR) is the most common diabetic eye disease and the worldwide leading cause of vision loss in working-age adults.

Funder

European Commission

Fundação para a Ciência e a Tecnologia

Programa Operacional Temático Factores de Competitividade

Publisher

Royal Society of Chemistry (RSC)

Subject

Biomedical Engineering,General Chemistry,Biochemistry,Bioengineering

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3